A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC

13 p | 11 | 2

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

10 p | 8 | 2

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer

11 p | 12 | 2

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen

7 p | 8 | 1

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

10 p | 10 | 1

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer: A study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres

10 p | 1 | 1